Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation
ROAM-DBS
ROAM-DBS
Sponsor study identifier
interventional
100
4 countries
18
Study Start
March 24, 2022
Actual (reported)Primary Completion
December 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of the ROAM-DBS study is to compare the time needed to achieve a 1 point improvement Patient's Global Impression of change (PGIC) relative to the subject's status at the end of the ADROIT initial programming visit in subjects who receive programming updates via in-clinic sessions and subjects who additionally have the option of receiving programming updates via Virtual Clinic sessions. The study intends to demonstrate shorter times to achieve benefit in the Virtual Clinic cohort.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 17, 2022
Actual (reported)March 8, 2022
Actual (reported)March 24, 2022
Actual (reported)December 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Efficacy Endpoint: The time to achieve a 1 point improvement Patient's Global Impression of change (PGIC) relative to the subject's status at the end of the initial programming visit
The PGI consists of 2 subscales, the first rating the severity of illness (PGIS) and the second evaluating the change in illness relative to a previous status (PGIC). The PGI scale evaluates all aspects of health and assesses if there has been a change in clinical status. The scale consists of two items, one scale rating severity of illness and one rating global improvement. Severity is rated from 1=normal/not at all ill to 7= extremely ill. Global improvement is rated from 1=very much improved to 7=very much worse. The questionnaire takes approximately 5 minutes to complete. The time needed to achieve a 1 point improvement Patient's Global Impression of change (PGIC) relative to the subject's status at the end of the initial programming visit in subjects who receive programming updates via in-clinic sessions and subjects who additionally have the option of receiving programming updates via Virtual Clinic sessions, will be compared.
PGIC will be collected within 2 days (48 hours) after completion of each programming visit
Primary Safety Endpoint: Rate of programming related adverse events for the Virtual Clinic cohort
The rate of programming related adverse events reported up to the Short Term (3 month) follow-up visit for the Virtual Clinic cohort will be summarized using counts and percentages.
At 3-months after initial programming visit
Patient Global Impression (PGI)
At 3-months after initial programming visit
Patient Global Impression (PGI)
At 1 Year after initial programming visit
Clinical Global Impression (CGI)
At 3-months after initial programming visit
Clinical Global Impression (CGI)
At 1 Year after initial programming visit
Parkinson's Disease Questionnaire (PDQ-39)
At 3-months after initial programming visit
Subjects who are implanted with Abbott Infinity DBS systems with the Neuosphere Virtual Clinic feature, and receive programming for their DBS system in-clinic only.
Subjects who are implanted with Abbott Infinity DBS systems with the Neuosphere Virtual Clinic feature, and receive programming for their DBS system with Virtual Clinic and in-clinic sessions.
Implant and initial programming of the Infinity DBS system for this cohort are conducted according to the sites standard of care. After initial programming, all follow-up programming for the first 3 months is conducted in-clinic (not using the Virtual Clinic feature).
Implant and initial programming of the Infinity DBS system for this cohort are conducted according to the sites standard of care. After initial programming, all follow-up programming for the first 3 months is conducted using Virtual Clinic or in-clinic as appropriate.
University of Arizona Health Sciences Center
Tucson, Arizona, 85274, United States
University of California at Davis
Sacramento, California, 95817, United States
University of Miami Hospital
Miami, Florida, 33136, United States
Rush University Medical Center
Chicago, Illinois, 60612, United States
Indiana University
Indianapolis, Indiana, 46202, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
Bradley White
Abbott
Devyani Nanduri
Abbott Medical Devices Neuromodulation
First Submitted
January 17, 2022
First Posted
March 8, 2022
Study Start
March 24, 2022
Actual (reported)Primary Completion
December 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Ohio State Medical
Columbus, Ohio, 43210, United States
Thomas Jefferson Department of Neurosurgery
Philadelphia, Pennsylvania, 19107, United States
Texas Movement Disorder Specialist
Georgetown, Texas, 78628, United States
Universitäts Klinikum Tübingen
Tübingen, Bad-wur, 72076, Germany
Medizinische Einrichtungen der Universität Düsseldorf
Düsseldorf, N. RHIN, 40225, Germany
UNIVERSITATSMEDIZIN der Johannes Gutenberg-Universität Mainz
Mainz, Rhinela, 55131, Germany
Hospital Universitari Germans Trias I Pujol
Badalona, 08916, Spain
Hospital Universitario de la Princesa
Madrid, 28006, Spain
Hospital Virgen de Rocio
Seville, 41013, Spain
Queen Elizabeth University Hospital
Glasgow, Wdbtshr, G51 4TF, United Kingdom
Study Completion
December 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 21, 2023
Record last verified: 2023-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: